“Stephen Foley: Big Pharma ignores R&D at its peril”
Up one level
—
filed under:
News
Business Comment on “The Independent”
"It might be a little early to declare, but 2010 looks like being a year of profound change for Big Pharma.
Almost as if a management consulting-led fad has swept through the industry, the world's biggest drug makers are, one by one, declaring a shift away from research and development spending….”
